Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Chronic myelogenous leukemia cytarabine

Guilhot, F. et al., Interferon alfa-2b combined with cytarabine versus interferon alone in chronic myelogenous leukemia. French Chronic Myeloid Leukemia Study Group, N. Engl. [Pg.166]

Hensley ML, Peterson B, Silver RT, Larson RA, Schiffer CA, Szatrowski TP. Risk factors for severe neuropsychiatric toxicity in patients receiving interferon alfa-2b and low-dose cytarabine for chronic myelogenous leukemia analysis of Cancer and Leukemia Group B 9013. J Clin Oncol 2000 18(6) 1301-8. [Pg.710]

Kantarjian HM, O Brien S, Smith TL, Rios MB, Cortes J, Beran M, Koller C, Giles FJ, Andreeff M, Kornblau S, Giralt S, Keating MJ, Talpaz M. Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabine. J Clin Oncol 1999 17(l) 284-92. [Pg.1818]

See other pages where Chronic myelogenous leukemia cytarabine is mentioned: [Pg.674]    [Pg.1793]    [Pg.1801]    [Pg.423]   
See also in sourсe #XX -- [ Pg.1417 ]



SEARCH



Chronic myelogenous leukemia

Cytarabin

Cytarabine

Leukemia chronic

Myelogenous leukemia

© 2024 chempedia.info